SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-23-062009
Filing Date
2023-11-09
Accepted
2023-11-09 16:05:14
Documents
13
Period of Report
2023-11-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K vtyx-20231109.htm   iXBRL 8-K 49045
2 EX-99.1 vtyx-ex99_1.htm EX-99.1 151489
  Complete submission text file 0000950170-23-062009.txt   330532

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT vtyx-20231109_lab.xml EX-101.LAB 13904
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT vtyx-20231109.xsd EX-101.SCH 2460
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT vtyx-20231109_pre.xml EX-101.PRE 10224
7 EXTRACTED XBRL INSTANCE DOCUMENT vtyx-20231109_htm.xml XML 4890
Mailing Address 12790 EL CAMINO REAL, SUITE 200 SAN DIEGO CA 92130
Business Address 12790 EL CAMINO REAL, SUITE 200 SAN DIEGO CA 92130 (858) 945-2393
Ventyx Biosciences, Inc. (Filer) CIK: 0001851194 (see all company filings)

IRS No.: 832996852 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40928 | Film No.: 231392256
SIC: 2834 Pharmaceutical Preparations